• Study of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Hungary Poland Spain
  • Safety Study of Regulatory T Cells (Treg02) and Tacrolimus Discontinuation in Adult Liver Transplant Recipients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Germany
  • Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland Romania +1
  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Norway Sweden
  • Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

    Recruiting

    4 1
    Investigated Drugs:
    Spain
  • Study of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Hungary Latvia Lithuania Poland Romania
  • Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

    Recruiting

    2 1 1 1
    Bulgaria France Germany Italy Poland Portugal +2
  • Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Bulgaria Denmark Germany Greece Hungary Italy +2
  • Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

    Recruiting

    2 1
    Czechia Germany Hungary Poland Slovakia

powered by